Article Sidebar
Published:
Feb 14, 2022Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Licoflavanone exerts anticancer effects on human nasopharyngeal cancer cells via caspase activation, suppression of cell migration and invasion, and inhibition of m-TOR/PI3K/AKT pathway
Abstract
Purpose: To study the anticancer effect of licoflavanone against human nasopharyngeal HKI carcinoma, and the mechanism involved.
Methods: The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay was used to determine the effect of licoflavanone on cell viability, while DAPI staining and western blotting were used to study its proapoptotic effect. Morphological examination was performed under phase contrast microscopy. Transwell chamber assays were used to study cell migration and invasion. The expression levels of mTOR/PI3K/AKT signal pathway-related proteins were assayed by Western blotting.
Results: Licoflavanone markedly suppressed the proliferation of nasopharyngeal HK1 cancer cells in a concentration-reliant pattern (p < 0.01). The anticancer effects of licoflavanone were mediated via induction of pro-apoptotic effects and blocking of mTOR/PI3K/AKT signal pathway. Licoflavanone enhanced the activities of caspase-3, caspase-8, caspase-9 and cleaved caspase-3, as well as Bax and Bad. Moreover, licoflavanone blocked the migration and invasion of HK1 nasopharyngeal cancer cells.
Conclusion: Licoflavanone exerts potent anticancer effects on human nasopharyngeal cancer cells via caspase activation, inhibition of cell migration and cell invasion, and down-regulation of m-TOR/PI3K/AKT signal pathway. Therefore, licoflavanone may be a useful lead drug for the development of a treatment strategy for nasopharyngeal cancer.
